Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Total Current Liabilities (2016 - 2025)

Dexcom (DXCM) has disclosed Total Current Liabilities for 16 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 26.93% to $2.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Dec 2025, down 26.93% year-over-year, with the annual reading at $2.1 billion for FY2025, 26.93% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $2.1 billion at Dexcom, down from $3.3 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $3.3 billion in Q3 2025, with the low at $600.7 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 162.16% in 2023, then dropped 26.93% in 2025.
  • Over 5 years, Total Current Liabilities stood at $720.8 million in 2021, then soared by 155.17% to $1.8 billion in 2022, then dropped by 15.4% to $1.6 billion in 2023, then soared by 88.43% to $2.9 billion in 2024, then decreased by 26.93% to $2.1 billion in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $2.1 billion, $3.3 billion, and $3.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.